Published March 5, 2022 | Version v1
Journal article

Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/0526)

  • 1. NRG Oncology Statistics and Data Management Center, Philadelphia (United States)
  • 2. Mayo Clinic, Rochester (United States)
  • 3. Sydney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia (United States)
  • 4. The University of Tennessee Health Science Center, Memphis (United States)

Description

We report efficacy of a prospective phase 2 trial (NCT00450411) of salvage low-dose-rate (LDR) prostate brachytherapy (BT) for local failure (LF) after prior external beam radiation therapy (EBRT) with minimum 5-years' follow-up.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2021.10.138

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2021.10.138;
PII
S0360301621030480;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
112
Journal Issue
4
Journal Page Range
vp.
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53122262
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BRACHYTHERAPY; DOSE RATES; EXTERNAL BEAM RADIATION THERAPY; FAILURES; PROSTATE
Descriptors DEC
BODY; GLANDS; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RADIOTHERAPY; THERAPY

Optional Information

Copyright
Copyright (c) 2021 Elsevier Inc. All rights reserved.